世界の慢性疲労症候群治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Fatigue Syndrome Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5659
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、慢性疲労症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤＆NSAID、抗うつ薬＆抗精神病薬、抗菌薬＆免疫調節薬）、用途別市場規模（病院、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・慢性疲労症候群治療薬の市場動向
・企業の競争状況、市場シェア
・慢性疲労症候群治療薬の種類別市場規模と予測2016-2027（鎮痛剤＆NSAID、抗うつ薬＆抗精神病薬、抗菌薬＆免疫調節薬）
・慢性疲労症候群治療薬の用途別市場規模と予測2016-2027（病院、小売薬局、その他）
・慢性疲労症候群治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・慢性疲労症候群治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・慢性疲労症候群治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・慢性疲労症候群治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・慢性疲労症候群治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Teva、Mylan、Depomed、Mallinckrodt Pharmaceuticals、Eli Lilly、Bayer、Novartis、Sun Pharmaceutical、Astrazeneca、Lundbeck、Arbor Pharma）
・結論

Chronic fatigue syndrome, also known as Myalgic encephalomyelitis, is a chronic disease which lasts for six months and affects the central nervous system and the immune system. The disease leads to musculoskeletal disorders, impairment of long term memory, and disturbed sleep patterns. This results in substantial decline in social, occupational, educational, and personal activity among patients. There are no specific biomarkers or tests to diagnose chronic fatigue syndrome. Symptoms include sore throat, muscle pain, headache, and fatigue, which continues for months or years.

Market Analysis and Insights: Global Chronic Fatigue Syndrome Drug Market
The global Chronic Fatigue Syndrome Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Fatigue Syndrome Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Fatigue Syndrome Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Fatigue Syndrome Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Fatigue Syndrome Drug market.

Global Chronic Fatigue Syndrome Drug Scope and Market Size
Chronic Fatigue Syndrome Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Fatigue Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pain Relievers and NSAIDs
Antidepressant and Antipsychotic Drugs
Antimicrobial and Immunomodulatory Drugs

Segment by Application
Hospital
Retail Pharmacy
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Teva
Mylan
Depomed
Mallinckrodt Pharmaceuticals
Eli Lilly
Bayer
Novartis
Sun Pharmaceutical
Astrazeneca
Lundbeck
Arbor Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Fatigue Syndrome Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pain Relievers and NSAIDs
1.2.3 Antidepressant and Antipsychotic Drugs
1.2.4 Antimicrobial and Immunomodulatory Drugs
1.3 Market by Application
1.3.1 Global Chronic Fatigue Syndrome Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Fatigue Syndrome Drug Market Perspective (2016-2027)
2.2 Chronic Fatigue Syndrome Drug Growth Trends by Regions
2.2.1 Chronic Fatigue Syndrome Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Fatigue Syndrome Drug Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Fatigue Syndrome Drug Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Fatigue Syndrome Drug Industry Dynamic
2.3.1 Chronic Fatigue Syndrome Drug Market Trends
2.3.2 Chronic Fatigue Syndrome Drug Market Drivers
2.3.3 Chronic Fatigue Syndrome Drug Market Challenges
2.3.4 Chronic Fatigue Syndrome Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Fatigue Syndrome Drug Players by Revenue
3.1.1 Global Top Chronic Fatigue Syndrome Drug Players by Revenue (2016-2021)
3.1.2 Global Chronic Fatigue Syndrome Drug Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Fatigue Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Fatigue Syndrome Drug Revenue
3.4 Global Chronic Fatigue Syndrome Drug Market Concentration Ratio
3.4.1 Global Chronic Fatigue Syndrome Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Fatigue Syndrome Drug Revenue in 2020
3.5 Chronic Fatigue Syndrome Drug Key Players Head office and Area Served
3.6 Key Players Chronic Fatigue Syndrome Drug Product Solution and Service
3.7 Date of Enter into Chronic Fatigue Syndrome Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Fatigue Syndrome Drug Breakdown Data by Type
4.1 Global Chronic Fatigue Syndrome Drug Historic Market Size by Type (2016-2021)
4.2 Global Chronic Fatigue Syndrome Drug Forecasted Market Size by Type (2022-2027)

5 Chronic Fatigue Syndrome Drug Breakdown Data by Application
5.1 Global Chronic Fatigue Syndrome Drug Historic Market Size by Application (2016-2021)
5.2 Global Chronic Fatigue Syndrome Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Fatigue Syndrome Drug Market Size (2016-2027)
6.2 North America Chronic Fatigue Syndrome Drug Market Size by Type
6.2.1 North America Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021)
6.2.2 North America Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027)
6.2.3 North America Chronic Fatigue Syndrome Drug Market Size by Type (2016-2027)
6.3 North America Chronic Fatigue Syndrome Drug Market Size by Application
6.3.1 North America Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021)
6.3.2 North America Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027)
6.3.3 North America Chronic Fatigue Syndrome Drug Market Size by Application (2016-2027)
6.4 North America Chronic Fatigue Syndrome Drug Market Size by Country
6.4.1 North America Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021)
6.4.2 North America Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chronic Fatigue Syndrome Drug Market Size (2016-2027)
7.2 Europe Chronic Fatigue Syndrome Drug Market Size by Type
7.2.1 Europe Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021)
7.2.2 Europe Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027)
7.2.3 Europe Chronic Fatigue Syndrome Drug Market Size by Type (2016-2027)
7.3 Europe Chronic Fatigue Syndrome Drug Market Size by Application
7.3.1 Europe Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021)
7.3.2 Europe Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027)
7.3.3 Europe Chronic Fatigue Syndrome Drug Market Size by Application (2016-2027)
7.4 Europe Chronic Fatigue Syndrome Drug Market Size by Country
7.4.1 Europe Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021)
7.4.2 Europe Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size (2016-2027)
8.2 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Type
8.2.1 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Application
8.3.1 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Region
8.4.1 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Fatigue Syndrome Drug Market Size (2016-2027)
9.2 Latin America Chronic Fatigue Syndrome Drug Market Size by Type
9.2.1 Latin America Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Fatigue Syndrome Drug Market Size by Type (2016-2027)
9.3 Latin America Chronic Fatigue Syndrome Drug Market Size by Application
9.3.1 Latin America Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Fatigue Syndrome Drug Market Size by Application (2016-2027)
9.4 Latin America Chronic Fatigue Syndrome Drug Market Size by Country
9.4.1 Latin America Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size (2016-2027)
10.2 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Type
10.2.1 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Application
10.3.1 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Country
10.4.1 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Chronic Fatigue Syndrome Drug Introduction
11.1.4 Pfizer Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Chronic Fatigue Syndrome Drug Introduction
11.2.4 Teva Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Chronic Fatigue Syndrome Drug Introduction
11.3.4 Mylan Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Depomed
11.4.1 Depomed Company Details
11.4.2 Depomed Business Overview
11.4.3 Depomed Chronic Fatigue Syndrome Drug Introduction
11.4.4 Depomed Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.4.5 Depomed Recent Development
11.5 Mallinckrodt Pharmaceuticals
11.5.1 Mallinckrodt Pharmaceuticals Company Details
11.5.2 Mallinckrodt Pharmaceuticals Business Overview
11.5.3 Mallinckrodt Pharmaceuticals Chronic Fatigue Syndrome Drug Introduction
11.5.4 Mallinckrodt Pharmaceuticals Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.5.5 Mallinckrodt Pharmaceuticals Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Chronic Fatigue Syndrome Drug Introduction
11.6.4 Eli Lilly Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Chronic Fatigue Syndrome Drug Introduction
11.7.4 Bayer Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Chronic Fatigue Syndrome Drug Introduction
11.8.4 Novartis Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Details
11.9.2 Sun Pharmaceutical Business Overview
11.9.3 Sun Pharmaceutical Chronic Fatigue Syndrome Drug Introduction
11.9.4 Sun Pharmaceutical Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.9.5 Sun Pharmaceutical Recent Development
11.10 Astrazeneca
11.10.1 Astrazeneca Company Details
11.10.2 Astrazeneca Business Overview
11.10.3 Astrazeneca Chronic Fatigue Syndrome Drug Introduction
11.10.4 Astrazeneca Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.10.5 Astrazeneca Recent Development
11.11 Lundbeck
11.11.1 Lundbeck Company Details
11.11.2 Lundbeck Business Overview
11.11.3 Lundbeck Chronic Fatigue Syndrome Drug Introduction
11.11.4 Lundbeck Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.11.5 Lundbeck Recent Development
11.12 Arbor Pharma
11.12.1 Arbor Pharma Company Details
11.12.2 Arbor Pharma Business Overview
11.12.3 Arbor Pharma Chronic Fatigue Syndrome Drug Introduction
11.12.4 Arbor Pharma Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021)
11.12.5 Arbor Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Fatigue Syndrome Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pain Relievers and NSAIDs
Table 3. Key Players of Antidepressant and Antipsychotic Drugs
Table 4. Key Players of Antimicrobial and Immunomodulatory Drugs
Table 5. Global Chronic Fatigue Syndrome Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Fatigue Syndrome Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Fatigue Syndrome Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Chronic Fatigue Syndrome Drug Market Share by Regions (2016-2021)
Table 9. Global Chronic Fatigue Syndrome Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Chronic Fatigue Syndrome Drug Market Share by Regions (2022-2027)
Table 11. Chronic Fatigue Syndrome Drug Market Trends
Table 12. Chronic Fatigue Syndrome Drug Market Drivers
Table 13. Chronic Fatigue Syndrome Drug Market Challenges
Table 14. Chronic Fatigue Syndrome Drug Market Restraints
Table 15. Global Chronic Fatigue Syndrome Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Chronic Fatigue Syndrome Drug Market Share by Players (2016-2021)
Table 17. Global Top Chronic Fatigue Syndrome Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Fatigue Syndrome Drug as of 2020)
Table 18. Ranking of Global Top Chronic Fatigue Syndrome Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Chronic Fatigue Syndrome Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Fatigue Syndrome Drug Product Solution and Service
Table 22. Date of Enter into Chronic Fatigue Syndrome Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Chronic Fatigue Syndrome Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Chronic Fatigue Syndrome Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Chronic Fatigue Syndrome Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Chronic Fatigue Syndrome Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Chronic Fatigue Syndrome Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Chronic Fatigue Syndrome Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Chronic Fatigue Syndrome Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Chronic Fatigue Syndrome Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Chronic Fatigue Syndrome Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Chronic Fatigue Syndrome Drug Product
Table 65. Pfizer Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Teva Company Details
Table 68. Teva Business Overview
Table 69. Teva Chronic Fatigue Syndrome Drug Product
Table 70. Teva Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Mylan Company Details
Table 73. Mylan Business Overview
Table 74. Mylan Chronic Fatigue Syndrome Drug Product
Table 75. Mylan Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 76. Mylan Recent Development
Table 77. Depomed Company Details
Table 78. Depomed Business Overview
Table 79. Depomed Chronic Fatigue Syndrome Drug Product
Table 80. Depomed Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 81. Depomed Recent Development
Table 82. Mallinckrodt Pharmaceuticals Company Details
Table 83. Mallinckrodt Pharmaceuticals Business Overview
Table 84. Mallinckrodt Pharmaceuticals Chronic Fatigue Syndrome Drug Product
Table 85. Mallinckrodt Pharmaceuticals Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 86. Mallinckrodt Pharmaceuticals Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Chronic Fatigue Syndrome Drug Product
Table 90. Eli Lilly Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Bayer Company Details
Table 93. Bayer Business Overview
Table 94. Bayer Chronic Fatigue Syndrome Drug Product
Table 95. Bayer Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 96. Bayer Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Sun Pharmaceutical Company Details
Table 102. Sun Pharmaceutical Business Overview
Table 103. Sun Pharmaceutical Chronic Fatigue Syndrome Drug Product
Table 104. Sun Pharmaceutical Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 105. Sun Pharmaceutical Recent Development
Table 106. Astrazeneca Company Details
Table 107. Astrazeneca Business Overview
Table 108. Astrazeneca Chronic Fatigue Syndrome Drug Product
Table 109. Astrazeneca Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 110. Astrazeneca Recent Development
Table 111. Lundbeck Company Details
Table 112. Lundbeck Business Overview
Table 113. Lundbeck Chronic Fatigue Syndrome Drug Product
Table 114. Lundbeck Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 115. Lundbeck Recent Development
Table 116. Arbor Pharma Company Details
Table 117. Arbor Pharma Business Overview
Table 118. Arbor Pharma Chronic Fatigue Syndrome Drug Product
Table 119. Arbor Pharma Revenue in Chronic Fatigue Syndrome Drug Business (2016-2021) & (US$ Million)
Table 120. Arbor Pharma Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Fatigue Syndrome Drug Market Share by Type: 2020 VS 2027
Figure 2. Pain Relievers and NSAIDs Features
Figure 3. Antidepressant and Antipsychotic Drugs Features
Figure 4. Antimicrobial and Immunomodulatory Drugs Features
Figure 5. Global Chronic Fatigue Syndrome Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Other Case Studies
Figure 9. Chronic Fatigue Syndrome Drug Report Years Considered
Figure 10. Global Chronic Fatigue Syndrome Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Fatigue Syndrome Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Fatigue Syndrome Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Fatigue Syndrome Drug Market Share by Regions (2022-2027)
Figure 14. Global Chronic Fatigue Syndrome Drug Market Share by Players in 2020
Figure 15. Global Top Chronic Fatigue Syndrome Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Fatigue Syndrome Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Fatigue Syndrome Drug Revenue in 2020
Figure 17. Global Chronic Fatigue Syndrome Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Fatigue Syndrome Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Fatigue Syndrome Drug Market Share by Type (2016-2027)
Figure 21. North America Chronic Fatigue Syndrome Drug Market Share by Application (2016-2027)
Figure 22. North America Chronic Fatigue Syndrome Drug Market Share by Country (2016-2027)
Figure 23. United States Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Fatigue Syndrome Drug Market Share by Type (2016-2027)
Figure 27. Europe Chronic Fatigue Syndrome Drug Market Share by Application (2016-2027)
Figure 28. Europe Chronic Fatigue Syndrome Drug Market Share by Country (2016-2027)
Figure 29. Germany Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Fatigue Syndrome Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Fatigue Syndrome Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Fatigue Syndrome Drug Market Share by Region (2016-2027)
Figure 39. China Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Fatigue Syndrome Drug Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Fatigue Syndrome Drug Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Fatigue Syndrome Drug Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Fatigue Syndrome Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Fatigue Syndrome Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Fatigue Syndrome Drug Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Fatigue Syndrome Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 59. Teva Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 61. Depomed Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 62. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 66. Sun Pharmaceutical Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 67. Astrazeneca Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 68. Lundbeck Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 69. Arbor Pharma Revenue Growth Rate in Chronic Fatigue Syndrome Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Myelodysplastic Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-4519 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、骨髄異形成症候群分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模...

世界の慢性片頭痛治療市場規模・現状・予測（2021年-2027年）

Global Chronic Migraine Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4013 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、慢性片頭痛治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、代替治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

Global HIV Associated Lipodystrophy Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4315 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、HIV関連リポジストロフィー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（特定薬剤治療、化粧品矯正治療）、用途別市場規模（病院、専門医クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年）

Global Usher Syndrome Threapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5003 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アッシャー症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NT-501、QRX-411、QRX-421、SAR-421869、その他）、用途別市場規模（クリニック、病院、その他）、主要地域...

世界のウェスト症候群市場規模・現状・予測（2021年-2027年）

Global West Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5039 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ウェスト症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のブルガダ症候群市場規模・現状・予測（2021年-2027年）

Global Brugada Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5638 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ブルガダ症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（大人、子供）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米...

世界の急性＆慢性肝不全市場規模・現状・予測（2021年-2027年）

Global Acute On Chronic Liver Failure Market Size, Status and Forecast 2021-2027
QFJ1-3759 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、急性＆慢性肝不全の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、医薬品、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年）

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6000 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、過敏性腸症候群（IBS）処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IBS-D薬、IBS-C薬、その他）、用途別市場規模（女性用、男性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5661 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年） Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. Market Analysis and Insights: Global Rx Irritable Bowel Syndrome (IBS) Drugs Market The global Rx Irritable Bowel Syndrome (IBS…
世界の後期慢性腎臓病治療薬市場規模・現状・予測（2021年-2027年） Late stage chronic kidney disease therapeutics can be defined as the drugs which are used for the treatment of late-stage CKD - Induced, Hyperphosphatemia, Hyperparathyroidism and Hyperkalemia. Market Analysis and Insights: Global Late Stage Chronic Kidney Disease Drugs Market The global Late Stage …
世界の慢性リンパ性白血病治療薬市場規模・現状・予測（2021年-2027年） Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes which are involved in the production of antibodies to fight against infections and foreign antigens. Rising incid…
世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年） Chronic gingivostomatitis is a common infection of mouth and gums, leading to drooling and swelling. Sometimes lesions in the mouth resembles the canker sores. This infection is common among children. Market Analysis and Insights: Global Chronic Gingivostomatitis Treatment Market The global Chronic …